Subtotal : 0.00Ks
Etratec
Add to Wishlist1. Each uncoated tablet contains:
Etravirine......
1. Each uncoated tablet contains:
Etravirine ………………. 200 mg
Excipients ………………….. q.s.
2. Indication and Usage:
ETRATEC is a human immunodeficiency virus type 1 (HIV-1) specific , non-nucleoside reverse transcriptase inhibitor (NNRTI) indicated:
In combination with other antiretroviral agents for the treatment of HIV-1 infection in treatment-experienced adult patients, who have evidence of viral replication and HIV-1 strains resistant to an NNRTI and other antiretroviral agents. In patients who have experienced virologic failure on an NNRTI-containing regimen, do not use ETRATEC in combination with only N[t]RTis.
The safety and efficacy of ETRATEC have not been established in pediatric patients or treatment-naive adult patients .
3. Dosage and administration:
The recommended oral dose of ETRATEC tablets is 200 mg taken twice daily following a meal. The type of food does not affect the exposure to etravirine
4. Contraindications:
None.
5. Adverse Reactions:
The most common adverse drug reactions of moderate to severe intensity(>/= 2%) which occurred at a higher rate than placebo are rash and peripheral neuropathy.
This medicine is Prescription Only Medicine (POM ) and required under medical supervision.
ဤဆေးသည် POM ဆေးအုပ်စုတွင်ပါဝင်သောကြောင့် ဆရာဝန်ညွှန်ကြားချက်အတိုင်းသာ သုံးစွဲသင့်ပါသည်။
Size : 30 tablets
Description
Etratec
1. Each uncoated tablet contains:
Etravirine ………………. 200 mg
Excipients ………………….. q.s.
2. Indication and Usage:
ETRATEC is a human immunodeficiency virus type 1 (HIV-1) specific , non-nucleoside reverse transcriptase inhibitor (NNRTI) indicated:
In combination with other antiretroviral agents for the treatment of HIV-1 infection in treatment-experienced adult patients, who have evidence of viral replication and HIV-1 strains resistant to an NNRTI and other antiretroviral agents. In patients who have experienced virologic failure on an NNRTI-containing regimen, do not use ETRATEC in combination with only N[t]RTis.
The safety and efficacy of ETRATEC have not been established in pediatric patients or treatment-naive adult patients .
3. Dosage and administration:
The recommended oral dose of ETRATEC tablets is 200 mg taken twice daily following a meal. The type of food does not affect the exposure to etravirine
4. Contraindications:
None.
5. Adverse Reactions:
The most common adverse drug reactions of moderate to severe intensity(>/= 2%) which occurred at a higher rate than placebo are rash and peripheral neuropathy.
This medicine is Prescription Only Medicine (POM ) and required under medical supervision.
ဤဆေးသည် POM ဆေးအုပ်စုတွင်ပါဝင်သောကြောင့် ဆရာဝန်ညွှန်ကြားချက်အတိုင်းသာ သုံးစွဲသင့်ပါသည်။
Add a review